Global Patent Index - EP 1638604 A2

EP 1638604 A2 20060329 - PASSIVE IMMUNE THERAPY AGAINST MALIGNANT MELANOMA

Title (en)

PASSIVE IMMUNE THERAPY AGAINST MALIGNANT MELANOMA

Title (de)

PASSIVE IMMUNTHERAPIE GEGEN MALIGNES MELANOM

Title (fr)

IMMUNOTHERAPIE PASSIVE CONTRE LE MELANOME MALIN

Publication

EP 1638604 A2 20060329 (DE)

Application

EP 04763003 A 20040617

Priority

  • EP 2004006519 W 20040617
  • DE 10328121 A 20030623

Abstract (en)

[origin: WO2005000349A2] Disclosed is the use of antibodies for producing an immunizing vaccine against HMW-MAA on melanomas.

IPC 1-7

A61K 39/395; A61P 35/00; C07K 16/30

IPC 8 full level

C07K 16/30 (2006.01)

CPC (source: EP)

A61P 35/00 (2017.12); C07K 16/3053 (2013.01); A61K 2039/505 (2013.01); C07K 2317/73 (2013.01)

Citation (search report)

See references of WO 2005000349A2

Citation (examination)

  • WO 8911296 A1 19891130 - FERRONE SOLDANO [US], et al
  • WILSON B S ET AL: "Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 15 SEP 1981 LNKD- PUBMED:7033148, vol. 28, no. 3, 15 September 1981 (1981-09-15), pages 293 - 300, ISSN: 0020-7136

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2005000349 A2 20050106; WO 2005000349 A3 20050506; AU 2004251010 A1 20050106; CA 2530655 A1 20050106; DE 10328121 A1 20050203; EP 1638604 A2 20060329; IL 172751 A0 20060410

DOCDB simple family (application)

EP 2004006519 W 20040617; AU 2004251010 A 20040617; CA 2530655 A 20040617; DE 10328121 A 20030623; EP 04763003 A 20040617; IL 17275105 A 20051222